Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mistletoe Therapy in Inoperable Pancreatic Cancer
NCT02948309Phase 3Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2016
- Primary completion
- Sep 2022
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pancreatic cancer (PC) comparing Mistletoe extract (Iscador Qu) with Placebo (2 arms). Primary endpoint: Overall Survival at 3 years. Started Jun 2016; status: completed.
02
Drugs
viscum album
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02948309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02948309.